CORT
insider transactionsCORCEPT THERAPEUTICS INC — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-314.0K
100.0K buy · 414.0K sell
Net value · 365d
-$22.0M
$3.3M in · $25.3M out
Sentiment · 365d
Net selling
12% buying · 88% selling
Open-market trades · 365d
25
100.0K buy · 414.0K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
Director
$1.7M
20.0K sh · $84.53
Own -43%
-
Sell·S
Director · 10b5-1
$486.6K
5.8K sh · $83.57
Own -1%
-
Sell·S
Director · 10b5-1
$345.4K
4.2K sh · $82.69
Own -0%
-
Exercise·M
Atabak Mokari KEY
Chief Financial Officer · 10b5-1
$0
40.0K sh
Own New
-
Sell·S
Atabak Mokari KEY
Chief Financial Officer · 10b5-1
$165
2 sh · $82.45
Own -0%
-
Sell·S
Atabak Mokari KEY
Chief Financial Officer · 10b5-1
$1.6M
19.5K sh · $81.81
Own -55%
-
Sell·S
Atabak Mokari KEY
Chief Financial Officer · 10b5-1
$896.9K
11.1K sh · $80.94
Own -24%
-
Sell·S
Atabak Mokari KEY
Chief Financial Officer · 10b5-1
$754.9K
9.4K sh · $80.02
Own -17%
-
Exercise·M
Atabak Mokari KEY
Chief Financial Officer · 10b5-1
$770.4K
40.0K sh · $19.26
Own +248%
-
Other·F
Chief Accounting & Technology…
$18.9K
269 sh · $70.44
Own -4%
-
Other·F
Sean Maduck KEY
President, Corcept Endocrinol… · 10b5-1
$31.8K
452 sh · $70.44
Own -4%
-
Other·F
Atabak Mokari KEY
Chief Financial Officer · 10b5-1
$27.8K
395 sh · $70.44
Own -2%
-
Other·F
Chief Business Officer
$25.2K
358 sh · $70.44
Own -1%
-
Exercise·M
Chief Development Officer · 10b5-1
$0
20.0K sh
Own +15%
-
Sell·S
Chief Development Officer · 10b5-1
$1.4M
20.0K sh · $70.60
Own -83%
-
Exercise·M
Chief Development Officer · 10b5-1
$433.0K
20.0K sh · $21.65
Own +502%
-
Sell·S
Chief Executive Officer · 10b5-1
$895.3K
12.8K sh · $69.74
Own -0%
-
Grant·A
Chief Accounting & Technology…
$0
537 sh
Own +8%
-
Grant·A
Chief Accounting & Technology…
$37.8K
537 sh · $70.44
Own +9%
-
Grant·A
Chief Development Officer
$0
877 sh
Own +28%
-
Grant·A
Chief Development Officer
$61.8K
877 sh · $70.44
Own +39%
-
Exercise·M
Sean Maduck KEY
President, Corcept Endocrinol… · 10b5-1
$0
25.0K sh
Own +21%
-
Grant·A
Sean Maduck KEY
President, Corcept Endocrinol… · 10b5-1
$0
615 sh
Own +6%
-
Grant·A
Sean Maduck KEY
President, Corcept Endocrinol… · 10b5-1
$43.3K
615 sh · $70.44
Own +7%
-
Sell·S
Sean Maduck KEY
President, Corcept Endocrinol… · 10b5-1
$278.1K
3.9K sh · $70.75
Own -30%
-
Sell·S
Sean Maduck KEY
President, Corcept Endocrinol… · 10b5-1
$1.5M
21.1K sh · $70.11
Own -62%
-
Exercise·M
Sean Maduck KEY
President, Corcept Endocrinol… · 10b5-1
$206.8K
25.0K sh · $8.27
Own +278%
-
Exercise·M
Atabak Mokari KEY
Chief Financial Officer · 10b5-1
$0
40.0K sh
Own +200%
-
Grant·A
Atabak Mokari KEY
Chief Financial Officer · 10b5-1
$0
634 sh
Own +4%
-
Grant·A
Atabak Mokari KEY
Chief Financial Officer · 10b5-1
$44.7K
634 sh · $70.44
Own +4%
-
Sell·S
Atabak Mokari KEY
Chief Financial Officer · 10b5-1
$2.8M
40.0K sh · $70.00
Own -72%
-
Exercise·M
Atabak Mokari KEY
Chief Financial Officer · 10b5-1
$770.4K
40.0K sh · $19.26
Own +262%
-
Grant·A
Chief Business Officer
$0
776 sh
Own +3%
-
Grant·A
Chief Business Officer
$54.7K
776 sh · $70.44
Own +3%
-
Other·G
Chief Executive Officer · 10b5-1
$0
150.0K sh
Own -50%
-
Other·G
Chief Executive Officer · 10b5-1
$0
300.0K sh
Own -10%
-
Sell·S
Chief Accounting & Technology…
$325.0K
5.0K sh · $65.00
Own -45%
-
Exercise·M
Sean Maduck KEY
President, Corcept Endocrinol… · 10b5-1
$0
75.0K sh
Own +82%
-
Sell·S
Sean Maduck KEY
President, Corcept Endocrinol… · 10b5-1
$1.4M
20.4K sh · $66.16
Own -69%
-
Sell·S
Sean Maduck KEY
President, Corcept Endocrinol… · 10b5-1
$3.6M
54.6K sh · $65.37
Own -65%
-
Exercise·M
Sean Maduck KEY
President, Corcept Endocrinol… · 10b5-1
$620.2K
75.0K sh · $8.27
Own +835%
-
Other·G
Director
$0
9.0K sh
Own -100%
-
Other·G
Director
$0
892.1K sh
Own -99%
-
Grant·A
Director
$0
12.5K sh
Own New
-
Grant·A
Director
$0
12.5K sh
Own New
-
Grant·A
Director
$0
12.5K sh
Own New
-
Grant·A
Director
$0
12.5K sh
Own New
-
Grant·A
Director
$0
12.5K sh
Own New
-
Grant·A
Director
$0
12.5K sh
Own New
-
Grant·A
Director
$0
12.5K sh
Own New
-
Other·G
Chief Business Officer
$0
1.0K sh
Own -7%
-
Other·G
Chief Business Officer
$0
5.3K sh
Own -18%
-
Exercise·M
Chief Development Officer · 10b5-1
$0
20.0K sh
Own +13%
-
Sell·S
Chief Development Officer · 10b5-1
$1.0M
20.0K sh · $51.83
Own -90%
-
Exercise·M
Chief Development Officer · 10b5-1
$433.0K
20.0K sh · $21.65
Own +896%
-
Sell·S
Chief Executive Officer · 10b5-1
$2.0M
40.0K sh · $50.10
Own -1%
-
Other·G
Director
$0
2.0K sh
Own -0%
-
Exercise·M
Chief Development Officer · 10b5-1
$0
20.0K sh
Own +12%
-
Sell·S
Chief Development Officer · 10b5-1
$819.4K
20.0K sh · $40.97
Own -90%
-
Exercise·M
Chief Development Officer · 10b5-1
$433.0K
20.0K sh · $21.65
Own +896%
-
Other·G
Director
$0
5.0K sh
Own -0%
-
Sell·S
Chief Executive Officer · 10b5-1
$1.3M
26.2K sh · $50.07
Own -1%
-
Other·G
Director
$0
4.0K sh
Own -0%
-
Exercise·M
Chief Development Officer · 10b5-1
$0
11.8K sh
Own +6%
-
Sell·S
Chief Development Officer · 10b5-1
$423.7K
11.8K sh · $36.01
Own -84%
-
Exercise·M
Chief Development Officer · 10b5-1
$254.8K
11.8K sh · $21.65
Own +527%
-
Buy·P
Director
$812.8K
24.2K sh · $33.56
Own +2%
-
Buy·P
Director
$2.5M
75.8K sh · $33.00
Own +7%
-
Other·G
Director
$0
28.0K sh
Own -2%
-
Exercise·M
Director
$0
30.0K sh
Own New
-
Other·J
Director
$0
24.5K sh
-
Other·G
Director
$0
24.5K sh
Own -100%
-
Other·F
Director
$175.8K
5.5K sh · $32.15
Own -18%
-
Exercise·M
Director
$175.8K
30.0K sh · $5.86
Own New
-
Exercise·M
Chief Development Officer · 10b5-1
$0
8.2K sh
Own +4%
-
Sell·S
Chief Development Officer · 10b5-1
$296.3K
8.2K sh · $35.99
Own -79%
-
Exercise·M
Chief Development Officer · 10b5-1
$178.2K
8.2K sh · $21.65
Own +369%
-
Other·F
Chief Accounting & Technology…
$3.2K
89 sh · $35.97
Own -1%
-
Other·F
Sean Maduck KEY
President, Corcept Endocrinol…
$4.0K
110 sh · $35.97
Own -1%
-
Other·F
Chief Business Officer
$4.4K
121 sh · $35.97
Own -0%
-
Other·F
Atabak Mokari KEY
Chief Financial Officer
$3.5K
96 sh · $35.97
Own -1%
-
Grant·A
Chief Accounting & Technology…
$0
398 sh
Own +4%
-
Grant·A
Chief Accounting & Technology…
$14.3K
398 sh · $35.97
Own +4%
-
Grant·A
Sean Maduck KEY
President, Corcept Endocrinol…
$0
454 sh
Own +5%
-
Grant·A
Sean Maduck KEY
President, Corcept Endocrinol…
$16.3K
454 sh · $35.97
Own +6%
-
Grant·A
Chief Business Officer
$0
499 sh
Own +1%
-
Grant·A
Chief Business Officer
$17.9K
499 sh · $35.97
Own +1%
-
Grant·A
Chief Development Officer
$0
498 sh
Own +29%
-
Grant·A
Chief Development Officer
$17.9K
498 sh · $35.97
Own +40%
-
Grant·A
Atabak Mokari KEY
Chief Financial Officer
$0
397 sh
Own +3%
-
Grant·A
Atabak Mokari KEY
Chief Financial Officer
$14.3K
397 sh · $35.97
Own +3%
-
Grant·A
Chief Accounting & Technology…
$0
140.0K sh
Own New
-
Grant·A
Atabak Mokari KEY
Chief Financial Officer
$0
140.0K sh
Own New
-
Grant·A
Sean Maduck KEY
President, Corcept Endocrinol…
$0
140.0K sh
Own New
-
Grant·A
Chief Scientific Officer
$0
140.0K sh
Own New
-
Grant·A
Chief Business Officer
$0
140.0K sh
Own New
-
Grant·A
Chief Development Officer
$0
140.0K sh
Own New
-
Grant·A
Chief Executive Officer
$0
460.0K sh
Own New
-
Exercise·M
Director
$0
100.0K sh
Own New
-
Other·J
Director
$0
89.4K sh
-
Other·G
Director
$0
89.4K sh
Own -100%
-
Other·F
Director
$388.0K
10.6K sh · $36.48
Own -11%
-
Exercise·M
Director
$388.0K
100.0K sh · $3.88
Own New
-
Exercise·M
Chief Scientific Officer
$0
150.0K sh
Own New
-
Other·F
Chief Scientific Officer
$3.2M
78.0K sh · $41.31
Own -23%
-
Exercise·M
Chief Scientific Officer
$582.0K
150.0K sh · $3.88
Own +82%
-
Exercise·M
Chief Development Officer · 10b5-1
$0
20.0K sh
Own +10%
-
Sell·S
Chief Development Officer · 10b5-1
$817.3K
20.0K sh · $40.87
Own -94%
-
Exercise·M
Chief Development Officer · 10b5-1
$433.0K
20.0K sh · $21.65
Own +1619%
-
Exercise·M
Director
$0
25.0K sh
Own New
-
Exercise·M
Director
$0
30.0K sh
Own New
-
Exercise·M
Director
$454.5K
30.0K sh · $15.15
Own +3%
-
Exercise·M
Director
$262.5K
25.0K sh · $10.50
Own +2%
-
Exercise·M
Director
$352.0K
25.0K sh · $14.08
Own +2%
-
Exercise·M
Director
$363.9K
30.0K sh · $12.13
Own +3%
-
Exercise·M
Director
$175.8K
30.0K sh · $5.86
Own +3%
-
Other·J
Sean Maduck KEY
President, Corcept Endocrinol…
$0
34.0K sh
-
Other·G
Sean Maduck KEY
President, Corcept Endocrinol…
$0
34.0K sh
Own -87%
-
Other·J
Sean Maduck KEY
President, Corcept Endocrinol…
$0
20.6K sh
-
Other·G
Sean Maduck KEY
President, Corcept Endocrinol…
$0
20.6K sh
Own -34%
-
Exercise·M
Chief Development Officer · 10b5-1
$0
20.0K sh
Own +9%
-
Sell·S
Chief Development Officer · 10b5-1
$703.7K
20.0K sh · $35.18
Own -94%
-
Exercise·M
Chief Development Officer · 10b5-1
$433.0K
20.0K sh · $21.65
Own +1619%
-
Other·G
Director
$0
0 sh
Own +0%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 17, 2026 | David L Mahoney | Sell S | 20.0K | $1.7M |
| Jun 16, 2026 | James N Wilson 10b5-1 | Sell S | 5.8K | $486.6K |
| Jun 16, 2026 | James N Wilson 10b5-1 | Sell S | 4.2K | $345.4K |
| Jun 15, 2026 | Atabak Mokari KEY 10b5-1 | Exercise M | 40.0K | $0 |
| Jun 15, 2026 | Atabak Mokari KEY 10b5-1 | Sell S | 2 | $165 |
| Jun 15, 2026 | Atabak Mokari KEY 10b5-1 | Sell S | 19.5K | $1.6M |
| Jun 15, 2026 | Atabak Mokari KEY 10b5-1 | Sell S | 11.1K | $896.9K |
| Jun 15, 2026 | Atabak Mokari KEY 10b5-1 | Sell S | 9.4K | $754.9K |
| Jun 15, 2026 | Atabak Mokari KEY 10b5-1 | Exercise M | 40.0K | $770.4K |
| Jun 2, 2026 | Joseph Douglas Lyon | Other F | 269 | $18.9K |
| Jun 2, 2026 | Sean Maduck KEY 10b5-1 | Other F | 452 | $31.8K |
| Jun 2, 2026 | Atabak Mokari KEY 10b5-1 | Other F | 395 | $27.8K |
| Jun 2, 2026 | Gary Charles Robb | Other F | 358 | $25.2K |
| Jun 2, 2026 | William Guyer 10b5-1 | Exercise M | 20.0K | $0 |
| Jun 2, 2026 | William Guyer 10b5-1 | Sell S | 20.0K | $1.4M |
| Jun 2, 2026 | William Guyer 10b5-1 | Exercise M | 20.0K | $433.0K |
| Jun 1, 2026 | Joseph K Belanoff KEY 10b5-1 | Sell S | 12.8K | $895.3K |
| Jun 1, 2026 | Joseph Douglas Lyon | Grant A | 537 | $0 |
| Jun 1, 2026 | Joseph Douglas Lyon | Grant A | 537 | $37.8K |
| Jun 1, 2026 | William Guyer | Grant A | 877 | $0 |
| Jun 1, 2026 | William Guyer | Grant A | 877 | $61.8K |
| Jun 1, 2026 | Sean Maduck KEY 10b5-1 | Exercise M | 25.0K | $0 |
| Jun 1, 2026 | Sean Maduck KEY 10b5-1 | Grant A | 615 | $0 |
| Jun 1, 2026 | Sean Maduck KEY 10b5-1 | Grant A | 615 | $43.3K |
| Jun 1, 2026 | Sean Maduck KEY 10b5-1 | Sell S | 3.9K | $278.1K |
| Jun 1, 2026 | Sean Maduck KEY 10b5-1 | Sell S | 21.1K | $1.5M |
| Jun 1, 2026 | Sean Maduck KEY 10b5-1 | Exercise M | 25.0K | $206.8K |
| Jun 1, 2026 | Atabak Mokari KEY 10b5-1 | Exercise M | 40.0K | $0 |
| Jun 1, 2026 | Atabak Mokari KEY 10b5-1 | Grant A | 634 | $0 |
| Jun 1, 2026 | Atabak Mokari KEY 10b5-1 | Grant A | 634 | $44.7K |
| Jun 1, 2026 | Atabak Mokari KEY 10b5-1 | Sell S | 40.0K | $2.8M |
| Jun 1, 2026 | Atabak Mokari KEY 10b5-1 | Exercise M | 40.0K | $770.4K |
| Jun 1, 2026 | Gary Charles Robb | Grant A | 776 | $0 |
| Jun 1, 2026 | Gary Charles Robb | Grant A | 776 | $54.7K |
| May 29, 2026 | Joseph K Belanoff KEY 10b5-1 | Other G | 150.0K | $0 |
| May 29, 2026 | Joseph K Belanoff KEY 10b5-1 | Other G | 300.0K | $0 |
| May 27, 2026 | Joseph Douglas Lyon | Sell S | 5.0K | $325.0K |
| May 27, 2026 | Sean Maduck KEY 10b5-1 | Exercise M | 75.0K | $0 |
| May 27, 2026 | Sean Maduck KEY 10b5-1 | Sell S | 20.4K | $1.4M |
| May 27, 2026 | Sean Maduck KEY 10b5-1 | Sell S | 54.6K | $3.6M |
| May 27, 2026 | Sean Maduck KEY 10b5-1 | Exercise M | 75.0K | $620.2K |
| May 27, 2026 | James N Wilson | Other G | 9.0K | $0 |
| May 27, 2026 | James N Wilson | Other G | 892.1K | $0 |
| May 21, 2026 | James N Wilson | Grant A | 12.5K | $0 |
| May 21, 2026 | Daniel N Swisher JR | Grant A | 12.5K | $0 |
| May 21, 2026 | Joshua M. Murray | Grant A | 12.5K | $0 |
| May 21, 2026 | David L Mahoney | Grant A | 12.5K | $0 |
| May 21, 2026 | Kimberly Park | Grant A | 12.5K | $0 |
| May 21, 2026 | Leonard G Baker JR | Grant A | 12.5K | $0 |
| May 21, 2026 | Gregg H Alton | Grant A | 12.5K | $0 |
| May 13, 2026 | Gary Charles Robb | Other G | 1.0K | $0 |
| May 13, 2026 | Gary Charles Robb | Other G | 5.3K | $0 |
| May 5, 2026 | William Guyer 10b5-1 | Exercise M | 20.0K | $0 |
| May 5, 2026 | William Guyer 10b5-1 | Sell S | 20.0K | $1.0M |
| May 5, 2026 | William Guyer 10b5-1 | Exercise M | 20.0K | $433.0K |
| May 1, 2026 | Joseph K Belanoff KEY 10b5-1 | Sell S | 40.0K | $2.0M |
| Apr 22, 2026 | James N Wilson | Other G | 2.0K | $0 |
| Apr 7, 2026 | William Guyer 10b5-1 | Exercise M | 20.0K | $0 |
| Apr 7, 2026 | William Guyer 10b5-1 | Sell S | 20.0K | $819.4K |
| Apr 7, 2026 | William Guyer 10b5-1 | Exercise M | 20.0K | $433.0K |
| Apr 6, 2026 | James N Wilson | Other G | 5.0K | $0 |
| Mar 25, 2026 | Joseph K Belanoff KEY 10b5-1 | Sell S | 26.2K | $1.3M |
| Mar 20, 2026 | James N Wilson | Other G | 4.0K | $0 |
| Mar 20, 2026 | William Guyer 10b5-1 | Exercise M | 11.8K | $0 |
| Mar 20, 2026 | William Guyer 10b5-1 | Sell S | 11.8K | $423.7K |
| Mar 20, 2026 | William Guyer 10b5-1 | Exercise M | 11.8K | $254.8K |
| Mar 17, 2026 | Leonard G Baker JR | Buy P | 24.2K | $812.8K |
| Mar 17, 2026 | Leonard G Baker JR | Buy P | 75.8K | $2.5M |
| Mar 13, 2026 | James N Wilson | Other G | 28.0K | $0 |
| Mar 13, 2026 | David L Mahoney | Exercise M | 30.0K | $0 |
| Mar 13, 2026 | David L Mahoney | Other J | 24.5K | $0 |
| Mar 13, 2026 | David L Mahoney | Other G | 24.5K | $0 |
| Mar 13, 2026 | David L Mahoney | Other F | 5.5K | $175.8K |
| Mar 13, 2026 | David L Mahoney | Exercise M | 30.0K | $175.8K |
| Mar 4, 2026 | William Guyer 10b5-1 | Exercise M | 8.2K | $0 |
| Mar 4, 2026 | William Guyer 10b5-1 | Sell S | 8.2K | $296.3K |
| Mar 4, 2026 | William Guyer 10b5-1 | Exercise M | 8.2K | $178.2K |
| Mar 3, 2026 | Joseph Douglas Lyon | Other F | 89 | $3.2K |
| Mar 3, 2026 | Sean Maduck KEY | Other F | 110 | $4.0K |
| Mar 3, 2026 | Gary Charles Robb | Other F | 121 | $4.4K |
| Mar 3, 2026 | Atabak Mokari KEY | Other F | 96 | $3.5K |
| Mar 2, 2026 | Joseph Douglas Lyon | Grant A | 398 | $0 |
| Mar 2, 2026 | Joseph Douglas Lyon | Grant A | 398 | $14.3K |
| Mar 2, 2026 | Sean Maduck KEY | Grant A | 454 | $0 |
| Mar 2, 2026 | Sean Maduck KEY | Grant A | 454 | $16.3K |
| Mar 2, 2026 | Gary Charles Robb | Grant A | 499 | $0 |
| Mar 2, 2026 | Gary Charles Robb | Grant A | 499 | $17.9K |
| Mar 2, 2026 | William Guyer | Grant A | 498 | $0 |
| Mar 2, 2026 | William Guyer | Grant A | 498 | $17.9K |
| Mar 2, 2026 | Atabak Mokari KEY | Grant A | 397 | $0 |
| Mar 2, 2026 | Atabak Mokari KEY | Grant A | 397 | $14.3K |
| Feb 27, 2026 | Joseph Douglas Lyon | Grant A | 140.0K | $0 |
| Feb 27, 2026 | Atabak Mokari KEY | Grant A | 140.0K | $0 |
| Feb 27, 2026 | Sean Maduck KEY | Grant A | 140.0K | $0 |
| Feb 27, 2026 | Hazel Hunt | Grant A | 140.0K | $0 |
| Feb 27, 2026 | Gary Charles Robb | Grant A | 140.0K | $0 |
| Feb 27, 2026 | William Guyer | Grant A | 140.0K | $0 |
| Feb 27, 2026 | Joseph K Belanoff KEY | Grant A | 460.0K | $0 |
| Feb 24, 2026 | James N Wilson | Exercise M | 100.0K | $0 |
| Feb 24, 2026 | James N Wilson | Other J | 89.4K | $0 |
| Feb 24, 2026 | James N Wilson | Other G | 89.4K | $0 |
| Feb 24, 2026 | James N Wilson | Other F | 10.6K | $388.0K |
| Feb 24, 2026 | James N Wilson | Exercise M | 100.0K | $388.0K |
| Feb 9, 2026 | Hazel Hunt | Exercise M | 150.0K | $0 |
| Feb 9, 2026 | Hazel Hunt | Other F | 78.0K | $3.2M |
| Feb 9, 2026 | Hazel Hunt | Exercise M | 150.0K | $582.0K |
| Feb 3, 2026 | William Guyer 10b5-1 | Exercise M | 20.0K | $0 |
| Feb 3, 2026 | William Guyer 10b5-1 | Sell S | 20.0K | $817.3K |
| Feb 3, 2026 | William Guyer 10b5-1 | Exercise M | 20.0K | $433.0K |
| Jan 27, 2026 | Leonard G Baker JR | Exercise M | 25.0K | $0 |
| Jan 27, 2026 | Leonard G Baker JR | Exercise M | 30.0K | $0 |
| Jan 27, 2026 | Leonard G Baker JR | Exercise M | 30.0K | $454.5K |
| Jan 27, 2026 | Leonard G Baker JR | Exercise M | 25.0K | $262.5K |
| Jan 27, 2026 | Leonard G Baker JR | Exercise M | 25.0K | $352.0K |
| Jan 27, 2026 | Leonard G Baker JR | Exercise M | 30.0K | $363.9K |
| Jan 27, 2026 | Leonard G Baker JR | Exercise M | 30.0K | $175.8K |
| Jan 8, 2026 | Sean Maduck KEY | Other J | 34.0K | $0 |
| Jan 8, 2026 | Sean Maduck KEY | Other G | 34.0K | $0 |
| Jan 8, 2026 | Sean Maduck KEY | Other J | 20.6K | $0 |
| Jan 8, 2026 | Sean Maduck KEY | Other G | 20.6K | $0 |
| Jan 6, 2026 | William Guyer 10b5-1 | Exercise M | 20.0K | $0 |
| Jan 6, 2026 | William Guyer 10b5-1 | Sell S | 20.0K | $703.7K |
| Jan 6, 2026 | William Guyer 10b5-1 | Exercise M | 20.0K | $433.0K |
| Jan 1, 2026 | Leonard G Baker JR | Other G | 0 | $0 |
About CORT insider trading
This page tracks insider transactions for CORCEPT THERAPEUTICS INC (CORT) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.